119 related articles for article (PubMed ID: 1997515)
1. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency.
Paolisso G; Scheen AJ; Giugliano D; Sgambato S; Albert A; Varricchio M; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1991 Mar; 72(3):607-15. PubMed ID: 1997515
[TBL] [Abstract][Full Text] [Related]
2. Effects of pulsatile delivery of insulin and glucagon in humans.
Paolisso G; Scheen AJ; Albert A; Lefebvre PJ
Am J Physiol; 1989 Nov; 257(5 Pt 1):E686-96. PubMed ID: 2688437
[TBL] [Abstract][Full Text] [Related]
3. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
[TBL] [Abstract][Full Text] [Related]
4. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes.
Paolisso G; Sgambato S; Torella R; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1988 Jun; 66(6):1220-6. PubMed ID: 3286673
[TBL] [Abstract][Full Text] [Related]
6. Insulin effects on glucose kinetics in non-insulin-dependent diabetic patients with secondary failure to hypoglycaemic agents: role of different modes and rates of delivery.
Paolisso G; Sgambato S; Varricchio M; Scheen AJ; D'Onofrio F; Lefèbvre P
Eur J Med; 1992 Sep; 1(5):261-7. PubMed ID: 1341607
[TBL] [Abstract][Full Text] [Related]
7. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of pulsatile insulin infusion in the elderly.
Paolisso G; Salvatore T; Sgambato S; Torella R; Varricchio M; D'Onofrio F
Acta Endocrinol (Copenh); 1990 Jul; 123(1):19-23. PubMed ID: 1975147
[TBL] [Abstract][Full Text] [Related]
9. Insulin-antagonistic effects of pulsatile and continuous glucagon infusions in man--a comparison with the effect of adrenaline.
Attvall S; Fowelin J; von Schenck H; Smith U; Lager I
J Clin Endocrinol Metab; 1992 May; 74(5):1110-5. PubMed ID: 1569157
[TBL] [Abstract][Full Text] [Related]
10. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F
Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096
[TBL] [Abstract][Full Text] [Related]
11. Increased action of pulsatile compared to non-pulsatile insulin delivery during a meal-like glucose exposure simulated by computerized infusion in healthy humans.
Juhl CB; Gjedsted J; Nielsen MF; Schmitz O
Metabolism; 2012 Aug; 61(8):1177-81. PubMed ID: 22386942
[TBL] [Abstract][Full Text] [Related]
12. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the priming effects of pulsatile and continuous insulin delivery on insulin action in man.
Courtney CH; Atkinson AB; Ennis CN; Sheridan B; Bell PM
Metabolism; 2003 Aug; 52(8):1050-5. PubMed ID: 12898472
[TBL] [Abstract][Full Text] [Related]
14. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
[TBL] [Abstract][Full Text] [Related]
15. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro.
Komjati M; Bratusch-Marrain P; Waldhäusl W
Endocrinology; 1986 Jan; 118(1):312-9. PubMed ID: 3000741
[TBL] [Abstract][Full Text] [Related]
16. Effects of mild-to-moderate hyperglycaemia per se on glucose production and uptake in the elderly.
Paolisso G; Marrazzo G; de Riu S; Sgambato S; Varricchio M; d'Onofrio F; Lefèbvre P
Eur J Med; 1992 Apr; 1(1):6-12. PubMed ID: 1341981
[TBL] [Abstract][Full Text] [Related]
17. Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age.
Paolisso G; Buonocore S; Gentile S; Sgambato S; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
Diabetologia; 1990 May; 33(5):272-7. PubMed ID: 2198186
[TBL] [Abstract][Full Text] [Related]
18. Similar effects of pulsatile and constant intravenous insulin delivery.
Kerner W; Brückel J; Zier H; Arias P; Thun C; Moncayo R; Pfeiffer EF
Diabetes Res Clin Pract; 1988 Apr; 4(4):269-74. PubMed ID: 3286166
[TBL] [Abstract][Full Text] [Related]
19. Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man.
Verdin E; Castillo M; Luyckx AS; Lefebvre PJ
Diabetes; 1984 Dec; 33(12):1169-74. PubMed ID: 6389233
[TBL] [Abstract][Full Text] [Related]
20. Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
Pal BR; Phillips PE; Matthews DR; Dunger DB
Diabetologia; 1992 Jun; 35(6):542-9. PubMed ID: 1612227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
